In patients with rheumatoid arthritis treated with anti-inflammatory medications, long-term persistent pain was found to be common and may be predicted by higher levels of disability and a history of smoking.
Participation in a long-term health-enhancing physical activity support program was associated with reduced global pain.
Non-episodic foot pain in hyperuricemia was responsive to urate-lowering therapy.
Mechanistic pain profiling may help predict response to treatment for knee osteoarthritis with nonsteroidal anti-inflammatory drugs plus paracetamol.
Four pain susceptibility phenotypes were identified in patients who had or were at risk for knee osteoarthritis, as well as risk factors for the development of persistent knee pain.
Patients generally experienced pain relief over 5 years regardless of whether they received physical therapy or arthroscopic partial menisectomy.
The numerical rating scale is the preferred patient-reported outcome measure for people with rheumatoid arthritis.
Centralized pain pathways may coexist with more established peripheral inflammation-driven pathways in some patients with rheumatoid arthritis.
Individuals using statins over 5 years and those using atorvastatin reported a lower risk for future osteoarthritis-related knee pain.
The combined effects of pain with insomnia and pain with depression increased diverse types of health care use.